Results 21 to 30 of about 2,113,927 (314)

Biomarkers in Neuroendocrine Tumors

JOP : Journal of the pancreas, 2013
Neuroendocrine tumors are a heterogeneous group of tumors with cells of neuroendocrine differentiation that arise from diverse anatomic sites with varying morphologic and clinical features. Since the natural history and prognosis varies widely between individual neuroendocrine tumor types, there is a critical need to identify accurate prognostic and ...
Marvin, Duque, Irvin M, Modlin, Anumeha, Gupta, Muhammad Wasif, Saif   +3 more
openaire   +2 more sources

Zyxin expression levels in non-small cell lung cancer patients [PDF]

Vojnosanitetski Pregled, 2020
Background/Aim. Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related mortality worldwide. Early detection represents one of the most promising approaches to reduce lung cancer mortality.
Ilić Dejan, Rančić Milan, Stoimenov-Jevtović Tatjana, Petrović Veljko, Petrović Marina   +4 more
doaj   +1 more source

Tumor Biomarkers in Melanoma

Cancer Control, 2009
Background Morphologic and histopathologic markers have been the backbone for the classification and prognostic assessment of melanoma. Availability of an increasing number of molecular markers, however, provides the potential for refining diagnostic and prognostic categories in this disease.
Selma, Ugurel, Jochen, Utikal, Jürgen C, Becker   +2 more
openaire   +2 more sources

Biomarkers of Mucinous Tumors of the Ovary [PDF]

Disease Markers, 2007
Goli Samimia,b, Laurent Ozbunb, Michael E. Johnsonc, Samuel C. Mokc and Michael J. Birrerb Cancer Prevention Fellowship Program, National Cancer Institute, Bethesda, MD 20892, USA Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA Laboratory of Gynecologic Oncology, Brigham and Women’s ...
Samimi, Goli, Ozbun, Laurent, Johnson, Michael E., Mok, Samuel C., Birrer, Michael J.   +4 more
openaire   +4 more sources

Human urinary exosomes in bladder cancer patients : properties, concentrations and possible clinical application [PDF]

, 2015
OBJECTIVE: High grade bladder cancer is extremely aggressive. Early detection is thus an important challenge. De- velopment of non-invasive diagnostic tools particularly using urine samples could be of importance in the diagnosis and surveillance of ...
Mullen, Peter, Chapman, Alex, Hacker, Christian, Leung, Steve, Lucocq, John Milton, Bowness, James Simeon, McLornan, Liz, Cameron, Ruth, Harrison, David James, Powis, Simon John, Chinn, David John, Riches, Andrew Clive   +11 more
core   +1 more source

Biomarkers in neuroendocrine tumors

Frontiers in Bioscience, 2010
Here, we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuro endocrine differentiation (defined as "pan ...
BERRETTA M, CAPPELLANI, Alessandro, DI VITA, Maria Domenica, BERRETTA S, NASTI G, BEARZ A, TIRELLI U, CANZONIERI V.   +7 more
openaire   +5 more sources

Circulating tumor cells as prognostic biomarkers in glioblastoma.

, 2021
Background: Glioblastoma (GBM) is the most common and aggressive type of tumor arising from the central nervous system. GBM remains an incurable disease despite current advancement in therapies, with survival rates of approximately 15 months.
Chua, Benjamin, Warkiani, Majid E, Punyadeera, Chamindie, Hartel, Gunter, Kulasinghe, Arutha, Leo, Paul, Jeffree, Rosalind L, Bark, Juliana Muller, Day, Bryan W   +8 more
core   +1 more source

Exosomes as a Source of Biomarkers for Gastrointestinal Cancers [PDF]

, 2023
Exosomes are small, lipid-bilayer bound extracellular vesicles of 40–160 nanometers in size that carry important information for intercellular communication.
Farshid Dayyani, Dayyani, Farshid, Ostowari, Arsha, Yu, Jingjing, Maheswari Senthil, Hughes, Christopher CW, Christopher C. W. Hughes, Gonda, Amber, Arsha Ostowari, Jingjing Yu, Mashayekhi, Kiarash, Yu, Jingjing,; Ostowari, Arsha,; Gonda, Amber,; Mashayekhi, Kiarash,; Dayyani, Farshid,; Hughes, Christopher CW,; Senthil, Maheswari,, Senthil, Maheswari, Amber Gonda, Kiarash Mashayekhi   +14 more
core   +1 more source

Cell-adhesion molecules and their soluble forms: Promising predictors of “tumor progression” and relapse in leukemia

Tumor Biology, 2018
Some surface markers are used to discriminate certain leukemic subpopulations that retain a greater oncogenic potential than others, and, for this reason, they were termed as leukemic stem cells, similar to the concept of cancer stem cells in carcinoma ...
Ieda Cristina Cunha Ferreira e Fonseca, Felipe Andrés Cordero da Luz, Isadora Akemi Uehara, Marcelo José Barbosa Silva   +3 more
doaj   +1 more source

Serum biomarkers and clinical characteristics of patients with Hodgkin lymphoma [PDF]

Vojnosanitetski Pregled, 2018
Background/Aim. In classical Hodgkin’s lymphoma (cHL) the existing prognostic scoring systems do not include markers that adequately reflect the interaction of malignant Hodgkin and Reed-Sternberg (HRS) cells and tumor environment.
Simonović Olivera, Todorović Milena, Mihaljević Biljana, Stoimenov-Jevtović Tatjana, Petković Ivan, Mačukanović-Golubović Lana, Marjanović Goran   +6 more
doaj   +1 more source